PCSA - Processa Pharmaceuticals, Inc.
3.51
0.150 4.274%
Share volume: 129,588
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$3.36
0.15
0.04%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 10-30-2024 | 05-10-2024 | 08-13-2024 | 10-30-2024 | 03-20-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Assets | |||||||||
| Total Assets | 5.787 M | 9.945 M | 7.601 M | 4.942 M | 3.229 M | 4.810 M | 8.182 M | 7.585 M | |
| Current Assets | 5.632 M | 9.800 M | 7.478 M | 4.838 M | 1.874 M | 3.758 M | 7.154 M | 6.587 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.706 M | 8.920 M | 5.571 M | 2.891 M | 1.191 M | 2.897 M | 6.937 M | 6.308 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.554 K | 2.415 K | 2.276 K | 5.317 K | 5.016 K | 4.715 K | 4.414 K | 4.113 K | |
| Other Assets | 151.592 K | 142.024 K | 120.726 K | 98.696 K | 1.351 M | 1.047 M | 1.024 M | 993.701 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 5.787 M | 9.945 M | 7.601 M | 4.942 M | 3.229 M | 4.810 M | 8.182 M | 7.585 M | |
| Total liabilities | 797.484 K | 1.061 M | 1.577 M | 1.221 M | 1.533 M | 1.283 M | 2.075 M | 1.751 M | |
| Total current liabilities | 730.579 K | 1.011 M | 1.552 M | 1.219 M | 1.533 M | 1.283 M | 2.075 M | 1.751 M | |
| Accounts Payable | 311.617 K | 455.368 K | 953.086 K | 711.710 K | 880.880 K | 552.560 K | 785.754 K | 727.172 K | |
| Other liabilities | 66.905 K | 50.700 K | 25.648 K | 2.168 K | 487.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 66.905 K | 50.700 K | 25.648 K | 2.168 K | 487.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.989 M | 8.883 M | 6.024 M | 3.721 M | 1.696 M | 3.527 M | 6.107 M | 5.834 M | |
| Common stock | 80.658 M | 87.279 M | 87.429 M | 88.511 M | 89.215 M | 93.880 M | 100.395 M | 103.558 M | |
| Retained earnings | -75.369 M | -78.095 M | -81.106 M | -84.490 M | -87.219 M | -90.054 M | -93.988 M | -97.424 M |